Annexin V-FITC/PI Apoptosis Detection Kit

SKU:BHT20800102 Kits & Workflows
Research Validated
Overview
Click light‑blue chips for details
The Annexin V-FITC/PI Apoptosis Detection Kit is an apoptosis detection kit from Yeasen Biotechnology for flow cytometry and fluorescence microscopy. It distinguishes viable, early-apoptotic, and late-apoptotic/necrotic cells via Annexin V-FITC and propidium iodide (PI) co-staining. Supplied as a pre-optimized kit with all critical reagents included. For Research Use Only (RUO).
Kit Category Detection / Quantification Kits
Grade RUO
Storage -20°C
Shipping Dry Ice
Options selector
Catalog no. Size
40302ES20 20 T
40302ES50 50 T
40302ES60 100 T
Available Options
This Annexin V-FITC/PI Apoptosis Detection Kit is supplied as a ready-to-use liquid kit and is offered in three sizes — 20 tests (40302ES20), 50 tests (40302ES50), and 100 tests (40302ES60) — so you can match the pack to your experiment throughput. All sizes are in stock at the manufacturer and ship after a short processing time; the kit is shipped on dry ice and stored at −20 °C.
Field Specification
Mfr No 40302ES
Product Type
  • Apoptosis Detection Kit
Shipping Dry Ice
Storage -20°C

Description

The Annexin V-FITC/PI Apoptosis Detection Kit is a ready-to-use flow cytometry assay for quantifying apoptosis in live, intact cells. By pairing FITC-conjugated Annexin V with propidium iodide (PI), it resolves viable, early-apoptotic, and late-apoptotic/necrotic populations in a single stain — a reliable workflow for apoptosis detection by flow cytometry or fluorescence microscopy.

FormatLiquid, ready-to-use
DetectionFlow cytometry / microscopy
FluorophoresFITC (Ex 488 nm) + PI
Kit sizes20 / 50 / 100 tests
Storage−20 °C
GradeResearch Use Only

How Annexin V/PI staining detects apoptosis

In healthy cells, phosphatidylserine (PS) faces the inner leaflet of the plasma membrane. Early in apoptosis, PS translocates to the cell surface before membrane integrity is lost. Annexin V is a Ca2+-dependent phospholipid-binding protein (35–36 kDa) with high affinity for PS, so FITC-labeled Annexin V binds externalized PS and identifies early-apoptotic cells.

Propidium iodide (PI) cannot cross the intact membrane of viable or early-apoptotic cells, but enters once membrane integrity is lost, staining the nuclei of late-apoptotic and necrotic cells. Used together, Annexin V and PI separate four populations in a single measurement: viable (Annexin V−/PI−), early apoptotic (Annexin V+/PI−), late apoptotic or necrotic (Annexin V+/PI+), and damaged or necrotic (Annexin V−/PI+).

Key features

  • All reagents supplied in ready-to-use liquid form — no reconstitution required.
  • Validated for both flow cytometry and fluorescence microscopy.
  • Clear four-quadrant resolution of viable, early-apoptotic, and late-apoptotic/necrotic cells.
  • Bright, well-separated FITC and PI signals for straightforward gating and imaging.

Result interpretation

Staining pattern Cell population
Annexin V− / PI− Viable cells
Annexin V+ / PI− Early apoptotic cells
Annexin V+ / PI+ Late apoptotic / necrotic cells
Annexin V− / PI+ Necrotic or mechanically damaged cells

Annexin V/PI staining protocol (flow cytometry)

  1. Harvest cells gently (Accutase is preferred over trypsin) and avoid mechanical stress. Collect approximately 1–5 × 105 cells per sample.
  2. Wash cells twice with cold PBS, then resuspend in 1× Binding Buffer.
  3. Add Annexin V-FITC and PI Staining Solution according to the kit manual (typically 5 µL Annexin V-FITC and 5–10 µL PI per test); mix gently.
  4. Incubate for 10–15 min at room temperature, protected from light.
  5. Add 1× Binding Buffer and analyze by flow cytometry within 1 hour (488 nm excitation; FITC detected at ~530 nm, PI at ~617 nm). Do not fix cells before Annexin V staining.

Include unstained, Annexin V-only, and PI-only single-stain controls to set compensation and gating. Refer to the product manual for the full validated protocol.

Apoptosis assay comparison

Method What it detects Best suited for
Annexin V / PI (this kit) Phosphatidylserine externalization (early) and loss of membrane integrity (late) Live, intact cells by flow cytometry or fluorescence microscopy
TUNEL DNA fragmentation (late apoptosis) Fixed cells and tissue sections
Caspase-3/7 activity Effector caspase activation Mechanistic confirmation of the apoptotic pathway

Specifications

Assay type Annexin V-FITC / PI apoptosis detection (flow cytometry, fluorescence microscopy)
Detection targets Viable, early-apoptotic, and late-apoptotic / necrotic cells
Fluorophores Annexin V-FITC (Ex 488 nm / Em ~530 nm); propidium iodide (Em ~617 nm)
Sample type Live, intact cultured cells (single-cell suspension)
Kit sizes 20 T / 50 T / 100 T
Packing form Bottle
Storage −20 °C
Shipping Dry ice
Shelf life 12 months under recommended storage
Grade For Research Use Only (RUO)

Kit components

Component No. Name 40302ES20 (20T) 40302ES50 (50T) 40302ES60 (100T)
40302-A Annexin V-FITC 100 µL 250 µL 500 µL
40302-B PI Staining Solution 200 µL 500 µL 1.0 mL
40302-C 1× Binding Buffer 10 mL 25 mL 50 mL

Storage & shipping

Shipped on dry ice. Store at −15 °C to −25 °C (−20 °C nominal); stable for 1 year under recommended conditions. Aliquot to minimize repeated freeze–thaw cycles.

Annexin V-FITC/PI apoptosis detection kit flow cytometry result

What is the principle behind Annexin V-based apoptosis detection?

During early apoptosis, phosphatidylserine (PS) translocates from the inner to the outer leaflet of the plasma membrane before membrane integrity is lost. Annexin V binds PS with high affinity in a calcium-dependent manner, enabling early-apoptosis detection. Co-staining with propidium iodide (PI) discriminates: Annexin V⁺/PI⁻ = early apoptosis; Annexin V⁺/PI⁺ = late apoptosis/necrosis; Annexin V⁻/PI⁻ = viable cells.

What is the TUNEL assay and when should it be used instead of Annexin V?

TUNEL (Terminal deoxynucleotidyl transferase dUTP Nick End Labeling) detects DNA strand breaks — a late-stage hallmark of apoptosis — by enzymatically labeling 3′-OH termini with fluorescent dUTP. TUNEL is preferred for detecting apoptosis in fixed cells, tissue sections, or when intracellular markers are needed (e.g., co-staining with nuclear markers). Annexin V is suitable for live, intact cells analyzed by flow cytometry or fluorescence microscopy.

Which fluorescent channels does this apoptosis kit require on a flow cytometer?

Channel requirements depend on the kit format: FITC variants require a 488 nm laser with 530/30 nm BP filter; YSFluor 488 variants are similar; YSFluor 647 requires a 633/647 nm (red) laser with 660/20 nm or 670 LP filter. Confirm your cytometer's laser and filter configuration matches the kit's excitation/emission profile. PI (propidium iodide) is typically detected in the PE or PerCP channel (488 nm excitation, 610–620 nm emission).

How should cells be prepared to avoid false-positive results?

Avoid mechanical or chemical stress during harvest — use gentle enzymatic dissociation (Accutase preferred over trypsin) and keep cells at 4°C during staining. Wash with cold Annexin V Binding Buffer (calcium-containing) immediately before staining. Do not fix cells before Annexin V staining — fixation disrupts membrane phospholipid asymmetry. Process and analyze samples within 1 hour of staining to prevent signal drift.

Still have a question about this kit?Our scientific team is happy to help with protocols, specs, or custom formats.

Contact Us

Yeasen Biotechnology offers flexible customization options for many of its assay kits and detection reagents, including custom lot sizes, bulk ordering, and application-specific formulation adjustments. Volume pricing, custom packaging, and kit bundling may be available depending on the product and intended workflow. A Certificate of Analysis (CoA) and lot-specific QC data are provided with every order. For inquiries regarding large-volume orders, custom configurations, or integration into automated workflows, please contact the BioHippo team for a tailored quotation.

1
Du Y, Liang Z, Wang S, et al. Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates. Nat Med. 2022;28(2):272-282. doi:10.1038/s41591-021-01645-7 IF 53.4
2
Chen Q, Zhang F, Dong L, et al. SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs. Cell Res. 2021;31(3):247-258. doi:10.1038/s41422-020-0389-3 IF 25.6
3
Wang Z, Yu L, Wang Y, et al. Dynamic Adjust of Non-Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR-II Imaging Mediated Photothermal Therapy and Immunotherapy. Adv Sci (Weinh). 2022;9(8):e2104793. doi:10.1002/advs.202104793 IF 16.8
4
Zhang M, Shao W, Yang T, et al. Conscription of Immune Cells by Light-Activatable Silencing NK-Derived Exosome (LASNEO) for Synergetic Tumor Eradication [published online ahead of print, 2022 Jun 4]. Adv Sci (Weinh). 2022;e2201135. doi:10.1002/advs.202201135 IF 16.8
5
Wang Z, Gong X, Li J, et al. Oxygen-Delivering Polyfluorocarbon Nanovehicles Improve Tumor Oxygenation and Potentiate Photodynamic-Mediated Antitumor Immunity. ACS Nano. 2021;15(3):5405-5419. doi:10.1021/acsnano.1c00033 IF 15.9
6
Li Y, Cui K, Zhang Q, et al. FBXL6 degrades phosphorylated p53 to promote tumor growth. Cell Death Differ. 2021;28(7):2112-2125. doi:10.1038/s41418-021-00739-6 IF 15.8
7
Li X, Yong T, Wei Z, et al. Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat Commun. 2022;13(1):2794. Published 2022 May 19. doi:10.1038/s41467-022-30306-7 IF 14.9
8
Chen YY, Ge JY, Zhu SY, Shao ZM, Yu KD. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis. Nat Commun. 2022;13(1):791. Published 2022 Feb 10. doi:10.1038/s41467-022-28452-z IF 14.9
9
Wang XS, Zeng JY, Li MJ, Li QR, Gao F, Zhang XZ. Highly Stable Iron Carbonyl Complex Delivery Nanosystem for Improving Cancer Therapy. ACS Nano. 2020;14(8):9848-9860. doi:10.1021/acsnano.0c02516 IF 14.6
10
Wang M, Zhang L, Cai Y, et al. Bioengineered Human Serum Albumin Fusion Protein as Target/Enzyme/pH Three-Stage Propulsive Drug Vehicle for Tumor Therapy [published online ahead of print, 2020 Nov 17]. ACS Nano. 2020;10.1021/acsnano.0c07610. doi:10.1021/acsnano.0c07610 IF 14.6
11
Deng RH, Zou MZ, Zheng D, et al. Nanoparticles from Cuttlefish Ink Inhibit Tumor Growth by Synergizing Immunotherapy and Photothermal Therapy. ACS Nano. 2019;13(8):8618-8629. doi:10.1021/acsnano.9b02993 IF 13.9
12
Zhao H, Xu J, Huang W, et al. Spatiotemporally Light-Activatable Platinum Nanocomplexes for Selective and Cooperative Cancer Therapy. ACS Nano. 2019;13(6):6647-6661. doi:10.1021/acsnano.9b00972 IF 13.9
13
Zhang C, Gao F, Wu W, et al. Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy. ACS Nano. 2019;13(10):11249-11262. doi:10.1021/acsnano.9b04315 IF 13.9
14
Wan SS, Cheng Q, Zeng X, Zhang XZ. A Mn(III)-Sealed Metal-Organic Framework Nanosystem for Redox-Unlocked Tumor Theranostics. ACS Nano. 2019;13(6):6561-6571. doi:10.1021/acsnano.9b00300 IF 13.9
15
Wei JL, Wu SY, Yang YS, et al. GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer. J Immunother Cancer. 2021;9(7):e002383. doi:10.1136/jitc-2021-002383 IF 13.8
16
Wang L, Qin W, Xu W, et al. Bacteria-Mediated Tumor Therapy via Photothermally-Programmed Cytolysin A Expression. Small. 2021;17(40):e2102932. doi:10.1002/smll.202102932 IF 13.3
17
Wan SS, Zhang L, Zhang XZ. An ATP-Regulated Ion Transport Nanosystem for Homeostatic Perturbation Therapy and Sensitizing Photodynamic Therapy by Autophagy Inhibition of Tumors. ACS Cent Sci. 2019;5(2):327-340. doi:10.1021/acscentsci.8b00822 IF 12.8
18
Sun D, Zou Y, Song L, et al. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharm Sin B. 2022;12(1):378-393. doi:10.1016/j.apsb.2021.06.005 IF 11.6
19
Yang Y, Hu D, Lu Y, et al. Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy. Acta Pharm Sin B. 2022;12(6):2710-2730. doi:10.1016/j.apsb.2021.08.021 IF 11.6
20
Hu Q, Jia L, Zhang X, Zhu A, Wang S, Xie X. Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional Chinese medicine. Acta Pharm Sin B. 2022;12(1):394-405. doi:10.1016/j.apsb.2021.05.021 IF 11.6
21
Wang M, Xu Y, Zhang Y, et al. Deciphering the autophagy regulatory network via single-cell transcriptome analysis reveals a requirement for autophagy homeostasis in spermatogenesis. Theranostics. 2021;11(10):5010-5027. Published 2021 Mar 5. doi:10.7150/thno.55645 IF 11.6
22
Xu X, Han C, Zhang C, Yan D, Ren C, Kong L. Intelligent phototriggered nanoparticles induce a domino effect for multimodal tumor therapy. Theranostics. 2021;11(13):6477-6490. Published 2021 Apr 19. doi:10.7150/thno.55708 IF 11.6
23
Fan Q, Zuo J, Tian H, et al. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells. J Exp Clin Cancer Res. 2022;41(1):162. Published 2022 May 3. doi:10.1186/s13046-022-02372-8 IF 11.2
24
Lei X, Cao K, Chen Y, et al. Nuclear Transglutaminase 2 interacts with topoisomerase IIα to promote DNA damage repair in lung cancer cells. J Exp Clin Cancer Res. 2021;40(1):224. Published 2021 Jul 5. doi:10.1186/s13046-021-02009-2 IF 11.2
25
Xu L, Wang Y, Song E, Song Y. Nucleophilic and redox properties of polybrominated diphenyl ether derived-quinone/hydroquinone metabolites are responsible for their neurotoxicity. J Hazard Mater. 2021;420:126697. doi:10.1016/j.jhazmat.2021.126697 IF 10.6
26
Zhang C, Peng SY, Hong S, et al. Biomimetic carbon monoxide nanogenerator ameliorates streptozotocin induced type 1 diabetes in mice. Biomaterials. 2020;245:119986. doi:10.1016/j.biomaterials.2020.119986 IF 10.3
27
Zhang L, Cheng Q, Li C, Zeng X, Zhang XZ. Near infrared light-triggered metal ion and photodynamic therapy based on AgNPs/porphyrinic MOFs for tumors and pathogens elimination. Biomaterials. 2020;248:120029. doi:10.1016/j.biomaterials.2020.120029 IF 10.3
28
Zhang C, Zheng DW, Li CX, et al. Hydrogen gas improves photothermal therapy of tumor and restrains the relapse of distant dormant tumor. Biomaterials. 2019;223:119472. doi:10.1016/j.biomaterials.2019.119472 IF 10.3
29
Cheng Q, Yu W, Ye J, et al. Nanotherapeutics interfere with cellular redox homeostasis for highly improved photodynamic therapy. Biomaterials. 2019;224:119500. doi:10.1016/j.biomaterials.2019.119500 IF 10.3
30
Zhong H, Huang PY, Yan P, et al. Versatile Nanodrugs Containing Glutathione and Heme Oxygenase 1 Inhibitors Enable Suppression of Antioxidant Defense System in a Two-Pronged Manner for Enhanced Photodynamic Therapy. Adv Healthc Mater. 2021;10(19):e2100770. doi:10.1002/adhm.202100770 IF 9.9
31
Dong J, Zhu C, Zhang F, Zhou Z, Sun M. "Attractive/adhesion force" dual-regulatory nanogels capable of CXCR4 antagonism and autophagy inhibition for the treatment of metastatic breast cancer. J Control Release. 2022;341:892-903. doi:10.1016/j.jconrel.2021.12.026 IF 9.8
32
Hu X, Tian H, Jiang W, Song A, Li Z, Luan Y. Rational Design of IR820- and Ce6-Based Versatile Micelle for Single NIR Laser-Induced Imaging and Dual-Modal Phototherapy. Small. 2018;14(52):e1802994. doi:10.1002/smll.201802994 IF 9.6
33
Yao Y, Li P, He J, Wang D, Hu J, Yang X. Albumin-Templated Bi2Se3-MnO2 Nanocomposites with Promoted Catalase-Like Activity for Enhanced Radiotherapy of Cancer. ACS Appl Mater Interfaces. 2021;13(24):28650-28661. doi:10.1021/acsami.1c05669 IF 9.2
34
Li X, Gui R, Li J, et al. Novel Multifunctional Silver Nanocomposite Serves as a Resistance-Reversal Agent to Synergistically Combat Carbapenem-Resistant Acinetobacter baumannii. ACS Appl Mater Interfaces. 2021;13(26):30434-30457. doi:10.1021/acsami.1c10309 IF 9.2
35
Liu J, Zhou B, Guo Y, et al. SR-A-Targeted Nanoplatform for Sequential Photothermal/Photodynamic Ablation of Activated Macrophages to Alleviate Atherosclerosis [published online ahead of print, 2021 Jun 16]. ACS Appl Mater Interfaces. 2021;10.1021/acsami.1c06380. doi:10.1021/acsami.1c06380 IF 9.2
36
Ye R, Zheng Y, Chen Y, et al. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity. ACS Appl Mater Interfaces. 2021;13(47):55902-55912. doi:10.1021/acsami.1c17618 IF 9.2
37
Luo Q, Lin L, Huang Q, et al. Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect. Acta Biomater. 2022;143:320-332. doi:10.1016/j.actbio.2022.02.033 IF 8.9
38
Sun J, Liu J, Gao C, et al. Targeted delivery of PARP inhibitors to neuronal mitochondria via biomimetic engineered nanosystems in a mouse model of traumatic brain injury. Acta Biomater. 2022;140:573-585. doi:10.1016/j.actbio.2021.12.023 IF 8.9
39
Gao J, Liu J, Meng Z, et al. Ultrasound-assisted C3F8-filled PLGA nanobubbles for enhanced FGF21 delivery and improved prophylactic treatment of diabetic cardiomyopathy. Acta Biomater. 2021;130:395-408. doi:10.1016/j.actbio.2021.06.015 IF 8.9
40
Xia F, Hou W, Liu Y, et al. Cytokine induced killer cells-assisted delivery of chlorin e6 mediated self-assembled gold nanoclusters to tumors for imaging and immuno-photodynamic therapy. Biomaterials. 2018;170:1-11. doi:10.1016/j.biomaterials.2018.03.048 IF 8.8
41
Xu M, Zhao X, Zhao S, et al. Landscape analysis of lncRNAs shows that DDX11-AS1 promotes cell-cycle progression in liver cancer through the PARP1/p53 axis. Cancer Lett. 2021;520:282-294. doi:10.1016/j.canlet.2021.08.001 IF 8.7
42
Hu XK, Rao SS, Tan YJ, et al. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK. Theranostics. 2020;10(17):7710-7729. Published 2020 Jun 19. doi:10.7150/thno.45858 IF 8.6
43
Wu D, Zhu ZQ, Tang HX, et al. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer. Theranostics. 2020;10(21):9808-9829. Published 2020 Aug 2. doi:10.7150/thno.43631 IF 8.6
44
Hong Y, Han Y, Wu J, et al. Chitosan modified Fe3O4/KGN self-assembled nanoprobes for osteochondral MR diagnose and regeneration. Theranostics. 2020;10(12):5565-5577. Published 2020 Apr 15. doi:10.7150/thno.43569 IF 8.6
45
Ding MH, Wang Z, Jiang L, et al. The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas. Biomaterials. 2015;56:165-178. doi:10.1016/j.biomaterials.2015.03.058 IF 8.6
46
Liang H, Zhou Z, Luo R, et al. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy. Theranostics. 2018;8(18):5059-5071. Published 2018 Oct 5. doi:10.7150/thno.28344 IF 8.5
47
Zhou Z, Zhang Q, Zhang M, et al. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy. Theranostics. 2018;8(17):4604-4619. Published 2018 Sep 9. doi:10.7150/thno.26889 IF 8.5
48
Qi HZ, Ye YL, Suo Y, et al. Wnt/β-catenin signaling mediates the abnormal osteogenic and adipogenic capabilities of bone marrow mesenchymal stem cells from chronic graft-versus-host disease patients. Cell Death Dis. 2021;12(4):308. Published 2021 Mar 23. doi:10.1038/s41419-021-03570-6 IF 8.5
49
He D, Ma Z, Xue K, Li H. Juxtamembrane 2 mimic peptide competitively inhibits mitochondrial trafficking and activates ROS-mediated apoptosis pathway to exert anti-tumor effects. Cell Death Dis. 2022;13(3):264. Published 2022 Mar 24. doi:10.1038/s41419-022-04639-6 IF 8.5
50
Xia J, Zhang J, Wang L, et al. Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation. Cell Death Dis. 2021;12(9):833. Published 2021 Sep 4. doi:10.1038/s41419-021-04126-4 IF 8.5

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today